CorMedix Inc (CRMD)

CorMedix Inc (CRMD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $576M; returns 1 day -3.1%, 1 week +8.1%, 1 year -30.6%.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions. The company's primary product is DefenCath (taurolidine and heparin), the first and only FDA-approved antimicrobial catheter lock solution in the U.S..

Groups CRMD belongs to

• Healthcare
• Biopharmaceutical
• Commercial Stage Biotech
• Pharmaceuticals
• Commercial Stage
• Infectious Diseases
• Antivirals
• Nephrology
• Gram-Negative Bacteria
• Strategic Acquisitions

CRMD financial model: income statement, cash flow and balance sheet